Innate immunity in COVID-19 patients mediated by NKG2A receptors, and potential treatment using Monalizumab, Cholroquine, and antiviral agents

出版年份 2020 全文链接

标题

作者

关键词

COVID-19, Innate immunity, NKG2A, Monalizumab, SARS

出版物

Volume 140, Issue -, Pages 109777

出版商

Elsevier BV

发表日期

2020-04-23

DOI

10.1016/j.mehy.2020.109777

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation